These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11467026)

  • 1. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales.
    Lamagni TL; Hope VD; Davison KL; Parry JV; Gill ON
    Commun Dis Public Health; 2001 Mar; 4(1):71-2. PubMed ID: 11467026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ
    Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996.
    Lamagni TL; Davison KL; Hope VD; Luutu JW; Newham JA; Parry JV; Gill ON
    Commun Dis Public Health; 1999 Sep; 2(3):174-7. PubMed ID: 10491870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis B in injecting drug users is increasing as initiative to improve vaccine coverage begins.
    Commun Dis Rep CDR Wkly; 1999 May; 9(21):183, 186. PubMed ID: 10379092
    [No Abstract]   [Full Text] [Related]  

  • 6. Increasing hepatitis B vaccine coverage in prisons in England and Wales.
    Gilbert RL; Costella A; Piper M; Gill ON
    Commun Dis Public Health; 2004 Dec; 7(4):306-11. PubMed ID: 15779795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users?
    Perrett K; Granerød J; Crowcroft N; Carlisle R
    Commun Dis Public Health; 2003 Jun; 6(2):97-100. PubMed ID: 12889286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
    Hope VD; Ncube F; Hickman M; Judd A; Parry JV
    J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the hepatitis B vaccination programme in prisons.
    Sutton AJ; Gay NJ; Edmunds WJ; Andrews NJ; Hope VD; Gilbert RL; Piper M; Gill ON
    Epidemiol Infect; 2006 Apr; 134(2):231-42. PubMed ID: 16490125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales.
    Winstock AR; Sheridan J; Lovell S; Farrell M; Strang J
    Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):823-8. PubMed ID: 11152306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
    Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
    J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study.
    Beck CR; Cloke R; O'Moore É; Puleston R
    Vaccine; 2012 Mar; 30(11):1965-71. PubMed ID: 22265944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
    Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
    Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination and injecting drug users.
    Budd J; Robertson R; Elton R
    Br J Gen Pract; 2004 Jun; 54(503):444-7. PubMed ID: 15186567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
    Day CA; White B; Dore GJ; van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L
    Drug Alcohol Depend; 2010 Apr; 108(1-2):134-7. PubMed ID: 20047803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced surveillance of acute symptomatic hepatitis B in England and Wales.
    Mangtani P; Heptonstall J; Hall AJ
    Commun Dis Public Health; 1998 Jun; 1(2):114-20. PubMed ID: 9644125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap.
    Maher L
    Int J Drug Policy; 2008 Dec; 19(6):425-8. PubMed ID: 18289840
    [No Abstract]   [Full Text] [Related]  

  • 20. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B.
    Ramsay ME; Balogun MA; Teo CG; Mortimer PP
    BMJ; 2000 Feb; 320(7233):512; author reply 513. PubMed ID: 10678875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.